{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:51Z","timestamp":1790352531842,"version":"4.1.0"},"reference-count":90,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 90682"],"award-info":[{"award-number":["UID 90682"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 98934"],"award-info":[{"award-number":["UID 98934"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["MRC-RFA-UFSP-01-2013"],"award-info":[{"award-number":["MRC-RFA-UFSP-01-2013"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,7,16]]},"abstract":"<jats:p>\n            As artemisinin combination therapies (ACTs) are compromised by resistance, we are evaluating triple combination therapies (TACTs) comprising an amino-artemisinin, a redox drug, and a third drug with different mode of action. Thus, here we briefly review efficacy data on artemisone, artemiside, other amino-artemisinins, and 11-aza-artemisinin and conduct absorption, distribution, and metabolism and excretion (ADME) profiling\n            <jats:italic>in vitro<\/jats:italic>\n            and pharmacokinetic (PK) profiling\n            <jats:italic>in vivo<\/jats:italic>\n            via intravenous (i.v.) and oral (p.o.) administration to mice.\n          <\/jats:p>","DOI":"10.1128\/aac.00990-21","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T22:38:48Z","timestamp":1623623928000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether"],"prefix":"10.1128","volume":"65","author":[{"given":"Daniel J.","family":"Watson","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizahn","family":"Laing","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0089-2136","authenticated-orcid":true,"given":"Liezl","family":"Gibhard","sequence":"additional","affiliation":[{"name":"H3D, Department of Chemistry, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Ning","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-1823","authenticated-orcid":true,"given":"Richard K.","family":"Haynes","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9070-8699","authenticated-orcid":true,"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Geneva: world malaria report 2019.","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. Geneva: world malaria report 2019."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30392-5"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00898-20"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08714"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009133"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12876"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu491"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3189"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70049-6"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-2024-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1813386115"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14412"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aac4781"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-10"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw388"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1942-5"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu142"},{"key":"e_1_3_3_20_2","unstructured":"World Health Organization Geneva. Global malaria programme August 2018 status report information and data. http:\/\/www.who.int\/malaria\/areas\/drug_resistance\/en\/"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30552-3"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200383"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2976-7"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30560-2"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30792-X"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002745"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2907-7"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30053-2"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10842-5"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0702"},{"key":"e_1_3_3_31_2","unstructured":"World Health Organization Geneva. The Mekong Malaria Elimination Programme - countries of the Greater Mekong ready for the \u201clast mile\u201d of malaria elimination; bulletin no. 9. December 2020. https:\/\/www.who.int\/publications\/i\/item\/WHO-UCN-GMP-MME-2020.05."},{"key":"e_1_3_3_32_2","volume-title":"A detailed chronological record of project 523 and the discovery and development of Qinghaosu (Artemisinin)","author":"Zhang JF","year":"2005","unstructured":"Zhang JF. 2005. A detailed chronological record of project 523 and the discovery and development of Qinghaosu (Artemisinin). Yang Cheng Evening News Publishing Company, Yang Cheng, China."},{"key":"e_1_3_3_33_2","volume-title":"Artemisinin-based and other antimalarials: detailed account of studies by Chinese scientists who discovered and developed them.","author":"Guoqiao L","year":"2018","unstructured":"Guoqiao L, Ying L, Zelin L, Meiyi Z (ed). 2018. Artemisinin-based and other antimalarials: detailed account of studies by Chinese scientists who discovered and developed them. Academic Press, Elsevier"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107658"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2010.542257"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.5214"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-478"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.38.8.1813"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033326"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.62.409"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408441003610571"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700064"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-212"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00183-15"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2174\/156802606776743129"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1039\/C4RA00879K"},{"key":"e_1_3_3_47_2","volume-title":"Artemisia annua, Artemisinin, ACTs and Malaria Control in Africa; Tradition, Science and Public Policy.","author":"Dalrymple DG","year":"2012","unstructured":"Dalrymple DG. 2012. Medicines for Malaria Venture (MMV), Geneva, Artemisia annua, Artemisinin, ACTs and Malaria Control in Africa; Tradition, Science and Public Policy. Politics & Prose, Washington, DC."},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02214-17"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00901"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-018-0062-7"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201600011"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200503071"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2018.04.027"},{"key":"e_1_3_3_54_2","first-page":"35","article-title":"Identification of non-neurotoxic artemisinin derivatives in vivo and in vitro","volume":"3","author":"Schmuck G","year":"2003","unstructured":"Schmuck G, Temerowski M, Haynes RK, Fugmann B. 2003. Identification of non-neurotoxic artemisinin derivatives in vivo and in vitro. Res Adv Antimicrob Agents Chemother 3:35\u201347.","journal-title":"Res Adv Antimicrob Agents Chemother"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01585-07"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-227"},{"key":"e_1_3_3_57_2","volume-title":"XVI international congress for tropical medicine and malaria: medicine and health in the tropics.","author":"Krudsood S","year":"2005","unstructured":"Krudsood S, Wilairatana P, Chalermrut K, Leowattana W, Voith B, Hampel B, et al. 2005. Artemifone, a new anti-malarial artemisinin derivative: open pilot trial to investigate the antiparasitic activity of BAY 44-9585 in patients with uncomplicated P. falciparum malaria. In XVI international congress for tropical medicine and malaria: medicine and health in the tropics."},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2724-z"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_23_20"},{"key":"e_1_3_3_60_2","unstructured":"U.S. National Library of Medicine. Artemisone for the treatment of uncomplicated falciparum malaria in Western Cambodia (AMOS). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00936767"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200400366"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700065"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700599"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02707-14"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00197-15"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1112037108"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02462-14"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(98)80208-2"},{"key":"e_1_3_3_69_2","volume-title":"Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization","author":"Kearns E","year":"2008","unstructured":"Kearns E, Di L. 2008. Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization, 1st ed. Academic Press.","edition":"1"},{"key":"e_1_3_3_70_2","unstructured":"Artemether: PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/68911#section=Solubility."},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/109563"},{"key":"e_1_3_3_72_2","unstructured":"Artemether: Drugbank; https:\/\/go.drugbank.com\/drugs\/DB06697."},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay071"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S76317"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.01.010"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050648"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2018.01.005"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00332-10"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003326"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498259309059425"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00042-6"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2053229618006320"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150729115752"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700600"},{"key":"e_1_3_3_86_2","volume-title":"SANS 10386:2008, edition 1. South African National Standard: The Care and Use of Animals for Scientific Purposes.","author":"South African Bureau of Standards","year":"2008","unstructured":"South African Bureau of Standards. 2008. SANS 10386:2008, edition 1. South African National Standard: The Care and Use of Animals for Scientific Purposes. SABS Standards Division, Pretoria, South Africa."},{"key":"e_1_3_3_87_2","volume-title":"Ethics in health research: principles, processes and structures","author":"Department of Health.","year":"2015","unstructured":"Department of Health. 2015. Ethics in health research: principles, processes and structures, 2nd ed. Department of Health, Republic of South Africa, Pretoria, South Africa.","edition":"2"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9203-3"},{"key":"e_1_3_3_89_2","first-page":"1350","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach RS","year":"1999","unstructured":"Obach RS. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350\u20131359.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.05.003"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02104-15"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00990-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00990-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:02:14Z","timestamp":1645484534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00990-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7,16]]}},"alternative-id":["10.1128\/AAC.00990-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00990-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2021-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00990-21"}}